Mortality As a Measure of Treatment Effect in Clinical Trials Recruiting Critically Ill Patients*

被引:8
|
作者
Friedrich, Jan O. [1 ,2 ]
Harhay, Michael O. [3 ]
Angus, Derek C. [4 ]
Burns, Karen E. A. [1 ,2 ]
Cook, Deborah J. [5 ]
Fergusson, Dean A. [6 ]
Finfer, Simon [7 ]
Hebert, Paul [8 ]
Rowan, Kathy [9 ]
Rubenfeld, Gordon [1 ,2 ,10 ]
Marshall, John C. [1 ,11 ]
机构
[1] Univ Toronto, St Michaels Hosp, Dept Crit Care Med, Toronto, ON, Canada
[2] Univ Toronto, St Michaels Hosp, Dept Med, Toronto, ON, Canada
[3] Univ Penn, Perelman Sch Med, Dept Biostat Epidemiol & Informat, Philadelphia, PA USA
[4] Univ Pittsburgh, CRISMA Ctr, Med Ctr, Pittsburgh, PA USA
[5] McMaster Univ, Hamilton, ON, Canada
[6] Ottawa Hosp, Res Inst, Ottawa, ON, Canada
[7] George Inst, Sydney, NSW, Australia
[8] Ctr Hosp Univ Montreal, Ctr Rech, Montreal, PQ, Canada
[9] Intens Care Natl Audit & Resource Ctr ICNARC, London, England
[10] Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada
[11] Univ Toronto, St Michaels Hosp, Dept Surg, Toronto, ON, Canada
基金
美国国家卫生研究院;
关键词
ARDS; critical care; mortality; sepsis; trials; RESPIRATORY-DISTRESS-SYNDROME; INTENSIVE-CARE; SEVERE SEPSIS; SEPTIC SHOCK; EFFICACY; SAFETY; MULTICENTER; OUTCOMES; HYDROCORTISONE; VENTILATION;
D O I
10.1097/CCM.0000000000005721
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
OBJECTIVES:All-cause mortality is a common measure of treatment effect in ICU-based randomized clinical trials (RCTs). We sought to understand the performance characteristics of a mortality endpoint by evaluating its temporal course, responsiveness to differential treatment effects, and impact when used as an outcome measure in trials of acute illness. DATA SOURCES:We searched OVID Medline for RCTs published from 1990 to 2018. STUDY SELECTION:We reviewed RCTs that had randomized greater than or equal to 100 patients, were published in one of five high-impact general medical or eight critical care journals, and reported mortality at two or more distinct time points. We excluded trials recruiting pediatric or neonatal patients and cluster RCTs. DATA EXTRACTION:Mortality by randomization group was recorded from the article or estimated from survival curves. Trial impact was assessed by inclusion of results in clinical practice guidelines. DATA SYNTHESIS:From 2,592 potentially eligible trials, we included 343 RCTs (228,784 adult patients). While one third of all deaths by 180 days had occurred by day 7, the risk difference between study arms continued to increase until day 60 (p = 0.01) and possibly day 90 (p = 0.07) and remained stable thereafter. The number of deaths at ICU discharge approximated those at 28-30 days (95% [interquartile range [IQR], 86-106%]), and deaths at hospital discharge approximated those at 60 days (99% [IQR, 94-104%]). Only 13 of 43 interventions (30.2%) showing a mortality benefit have been adopted into widespread clinical practice. CONCLUSIONS:Our findings provide a conceptual framework for choosing a time horizon and interpreting mortality outcome in trials of acute illness. Differential mortality effects persist for 60 to 90 days following recruitment. Location-based measures approximate time-based measures for trials conducted outside the United States. The documentation of a mortality reduction has had a modest impact on practice.
引用
收藏
页码:222 / 230
页数:9
相关论文
共 50 条
  • [1] Four Decades of Randomized Clinical Trials Influencing Mortality in Critically Ill and Perioperative Patients
    Romero, Carolina S.
    Romero, Esther
    Maimieri, Nicolo
    Popp, Maria
    Marchetti, Cristiano
    Lombardi, Gaetano
    Ortalda, Alessandro
    Zangrillo, Alberto
    Landoni, Giovanni
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2022, 36 (08) : 3327 - 3333
  • [2] Lactate and base deficit are predictors of mortality in critically ill patients with cancer
    Hajjar, Ludhmila Abrahao
    Nakamura, Rosana Ely
    de Almeida, Juliano Pinheiro
    Fukushima, Julia T.
    Gehm Hoff, Paulo Marcelo
    Vincent, Jean-Louis
    Costa Auler Junior, Jose Otavio
    Barbosa Gomes Galas, Filomena Regina
    CLINICS, 2011, 66 (12) : 2037 - 2042
  • [3] Interventions affecting mortality in critically ill and perioperative patients: A systematic review of contemporary trials
    Redaelli, Martina Baiardo
    Landoni, Giovanni
    Di Sanzo, Stefania
    Frassoni, Samuele
    Sartini, Chiara
    Cabrini, Luca
    Monti, Giacomo
    Scandroglio, Mara
    Zangrillo, Alberto
    Bellomo, Rinaldo
    JOURNAL OF CRITICAL CARE, 2017, 41 : 107 - 111
  • [4] Relationship with serum bilirubin levels and mortality in critically ill patients
    Akan, Belgin
    Gokcinar, Derya
    Ceran, Guzin
    Turan, Isil Ozkocak
    KUWAIT MEDICAL JOURNAL, 2021, 53 (04): : 436 - 440
  • [5] Improving clinical trials in the critically ill
    Angus, Derek C.
    Mira, Jean-Paul
    Vincent, Jean-Louis
    CRITICAL CARE MEDICINE, 2010, 38 (02) : 527 - 532
  • [6] Heterogeneity of treatment effect by baseline risk of mortality in critically ill patients: re-analysis of three recent sepsis and ARDS randomised controlled trials
    Santhakumaran, Shalini
    Gordon, Anthony
    Prevost, A. Toby
    O'Kane, Cecilia
    McAuley, Daniel F.
    Shankar-Hari, Manu
    CRITICAL CARE, 2019, 23 (1):
  • [7] Etomidate, Adrenal Function, and Mortality in Critically Ill Patients
    Sunshine, Jacob E.
    Deem, Steven
    Weiss, Noel S.
    Yanez, N. David
    Daniel, Stephen
    Keech, Katherine
    Brown, Marcia
    Treggiari, Miriam M.
    RESPIRATORY CARE, 2013, 58 (04) : 639 - 646
  • [8] The Effect of Insurance Status on Mortality and Procedural Use in Critically Ill Patients
    Lyon, Sarah M.
    Benson, Nicole M.
    Cooke, Colin R.
    Iwashyna, Theodore J.
    Ratcliffe, Sarah J.
    Kahn, Jeremy M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 184 (07) : 809 - 815
  • [9] Increased mortality in critically ill patients with mild or moderate hyperbilirubinemia
    Pierrakos, Charalampos
    Velissaris, Dimitrios
    Felleiter, Peter
    Antonelli, Massimo
    Vanhems, Philippe
    Sakr, Yasser
    Vincent, Jean-Louis
    JOURNAL OF CRITICAL CARE, 2017, 40 : 31 - 35
  • [10] Biomarkers as predictors of mortality in critically ill patients with solid tumors
    Dos Reis, Audrey M.
    Fruchtenicht, Ana V. G.
    De Athaydes, Luiza C.
    Loss, Sergio
    Moreira, Luis Fernando
    ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS, 2017, 89 (04): : 2921 - 2929